Scaling gene therapy manufacturing: what needs to change before commercialization?
08 Sept 2026
Gene Therapy Manufacturing
- What is the biggest manufacturing risk and bottleneck in gene therapy manufacturing
- When should commercial readiness planning begin?
- How much process change is too much after pivotal studies start? When to lock the process?
- How can companies reduce tech transfer and comparability risk?
- What will define manufacturing excellence in gene therapy over the next five years?
